Injuries, missing teeth and infection: PETA raises concerns from UMass monkey lab records
In hopes to better understand Alzheimer's disease, University of Massachusetts Amherst researchers began studying marmosets. But People for the Ethical Treatment of Animals (PETA) said the monkeys were harmed in the process, experiencing injuries, missing teeth and infections.
Now, PETA is asking the U.S. Department of Agriculture to investigate 'possible violations of the Animal Welfare Act (AWA).'
'The marmosets in Dr. [Agnès] Lacreuse's laboratory are being forced to spend their entire lives in a cage, enduring multiple major surgical procedures, frequent fluid restriction, lengthy restraint, and ultimately, death and dissection,' PETA neuroscientist Katherine Roe said in a statement. '... when you add how consistently Lacreuse and her laboratory staff fail to provide these long-suffering animals even the minimal care required by law, resulting in illnesses and injuries, it is absolutely infuriating. It should be shut down immediately.'
In April, the university and PETA settled a 2022 public records lawsuit after PETA had filed three public records requests over 16 months, but UMass did not produce appropriate materials as mandated by state records law, PETA claimed. PETA recently received the records and shared them with MassLive.
In the lawsuit, filed in Suffolk County Superior Court in Boston, PETA said that UMass researchers perform experiments that mistreat animals and house creatures, including marmoset monkeys and hamsters, in cramped and inhumane conditions.
The university maintains that the animal welfare organization's assertions misrepresent its laboratories and research.
'UMass experimenters have a long history of animal welfare violations, and these latest records show they are either unwilling or unable to meet bare minimum federal standards,' Roe said. 'PETA urges the USDA to investigate promptly and take appropriate action to force UMass into compliance.'
But UMass continues to emphasize the importance of animals in research projects stating that 'nearly every Nobel laureate in physiology or medicine has relied on animal data for their research,' including developing vaccines for COVID-19 and cancer immunotherapies.
'Before embarking on a project, researchers must carefully consider and justify why there is no alternative to an animal model, how many animals are necessary to answer specific questions, and provide a detailed protocol for experiments for approval. Our researchers are committed to caring for animal models with the highest ethical standards and with rigorous compliance with all applicable federal and state laws and guidelines,' UMass said in a statement.
The focus of PETA's inquiry was experiments that UMass said aim to better understand Alzheimer's disease by studying marmosets.
The monkeys' short lifespans — about a decade — and cognitive decline with age allow researchers to track brain function over a manageable timeline, compared to the decades it would take to study a human across their whole life.
UMass' experiments gauge cognitive functions in the marmosets by asking them to identify shapes and odors and solve tests using fine motor skills. The researchers also track the monkeys' sleep, according to an informational webpage.
PETA has previously levied an assortment of accusations against UMass concerning the research — that experimenters 'drill into [marmosets] skulls and implant electrodes,' that they 'cut out [monkeys] ovaries and heat the animals with hand warmers' and that they keep monkeys in solitary confinement.
UMass and lead UMass researcher Agnès Lacreuse dispute each of these complaints.
'An attending veterinarian oversees the care of animals, with oversight from the Institutional Animal Care and Use Committee (IACUC) that is established by federal mandate. All animal facilities are regulated for heat, air conditioning, ventilation, humidity, lighting and access. Facilities are cleaned and checked on a regular schedule in compliance with federal animal welfare laws. Animal Care staff feed, water, and check the animals' health and well-being every day, year-round. Animals are provided environmental enrichment, such as toys and treats as appropriate,' UMass said in a statement.
The researchers implant a 'small telemeter' on the monkeys' heads, just under the skin, to record brain activity, Lacreuse said. A licensed veterinarian conducts the surgery, she said, and allows researchers to track monkeys' sleep without disturbing them.
Lacreuse's website acknowledged neutering and spaying the animals, which for female marmosets involves removing their ovaries. The process is the same as with a house cat or pet dog, Lacreuse said, and the animals are given appropriate anesthetics and medications during the surgery conducted by a veterinarian.
The monkeys are also heated with hand warmers to simulate the symptoms of menopause, a process they do not go through naturally. While PETA has previously questioned the necessity and humanity of the experiment, Lacreuse said that understanding marmosets' ability to regulate their body temperature could prove key to understanding the symptoms of menopause, including hot flashes.
Part of the research involves studying women's health to understand why women make up two-thirds of Alzheimer's cases, Lacreuse said.
But the newly released records look at different aspects of the study and how UMass treats the animals.
The records state there were numerous health issues with the monkeys, including dental disease, broken teeth and chronic diarrhea.
The records state there were many follow-ups on 'loose stool outbreak in [the] colony' during October 2023. But PETA fears not enough was done.
'For many of these health issues, the records provide no indication that UMass made meaningful efforts to either treat the conditions effectively or investigate their underlying causes to prevent recurrence,' the letter to the USDA states.
Multiple records state some of the monkeys were 'thin.' This, PETA claims, 'could signal the onset of chronic wasting syndrome, a debilitating condition in marmosets associated with severe health deficits, including muscle loss, weakness, and organ dysfunction.'
Again, PETA worries UMass did not make 'meaningful or sustained efforts to investigate or address the animals' condition.'
PETA also claims UMass documented multiple incidents in which marmosets were injured 'due to improper handling, unsafe caging, or an altercation with a neighbor.'
For example, records show that a monkey named Chloe had a partial nail avulsion, which could've been caused by a cage conflict.
Other situations involved the marmosets being injured but it was unclear how.
On March 21, 2024, a marmoset named Gabrielle noted to be not bearing weight on her right rear leg. She was given painkillers, but a few days later she was 'still reluctant to use' the affected leg. UMass noted that on April 3, 2024, Gabrielle was observed climbing out of her hammock, but she seemed to not use her right leg and foot to grasp the side of her cage.
'On April 5, [2024] a notation in Gabrielle's records suggests that her leg may have been reinjured when she was captured for a cage wash,' PETA wrote regarding UMass' notes, adding that three days later she could not fully straighten the affected leg.
By the end of May, the marmoset's injury appeared to be 'stable and resolved,' according to records. But she continued to prefer to use the other leg at this point.
'While Gabrielle was administered painkillers meloxicam and gabapentin to address her leg injury, the records do not indicate that any effort was made to determine how she was injured,' PETA wrote.
The letter details issues with each of the 10 marmosets.
MassLive reporter Will Katcher contributed to this reporting.
More News
Read the original article on MassLive.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Politico
an hour ago
- Politico
RFK Jr.'s past claims shadow vaccine panel agenda
Presented by With help from Amanda Chu and Danny Nguyen Driving the Day ACIP AGENDA CHANGE — The agenda for next week's Advisory Committee on Immunization Practices meeting includes some notable differences from the notice posted in the Federal Register earlier this month, Sophie reports with POLITICO's Lauren Gardner. Most notably, the panel will hold two separate votes for the flu shot: one on influenza vaccines and another on influenza vaccines that contain thimerosal. In 2014, before he became health secretary, Robert F. Kennedy Jr. wrote a book in which he alleges the vaccine preservative thimerosal likely caused autism and should be banned — a claim that health agencies now under his control have said is unfounded. Thimerosal continues to be used as a preservative in multidose vaccine vials to inhibit germ growth. But its use in FDA-licensed flu vaccines has declined over the past 25 years as manufacturers reformulated their products and shifted to single-use vials. Most of those contain little or no thimerosal, according to the CDC. The meeting marks the first for Kennedy's revamped ACIP roster — following the firing of the previous 17 members — which includes several vaccine skeptics. No Covid vote: The agenda does not include a vote on Covid-19 vaccines, despite the Federal Register notice saying a vote is planned. Last month, Kennedy updated the CDC's Covid recommendations without a vote from the panel, breaking from tradition. Kennedy removed the recommendation that pregnant women get the shot, and the CDC changed the recommendation for healthy children to 'shared clinical decision making' — meaning children 'may' get vaccinated if their doctors and parents want them to. The HPV vaccine and meningococcal vaccine were also slated for a vote according to the meeting's Federal Register notice but aren't included in the draft agenda. Cut short? The agenda for the advisory committee's meeting includes only two days, June 25 and 26, but the initial Federal Register notice said the panel would also meet on June 27. A spokesperson for HHS did not comment on the thimerosal vote or why the agenda for the 27th wasn't included. WELCOME TO FRIDAY PULSE. For more on what next week's ACIP agenda holds, keep reading. Send your tips, scoops and feedback to khooper@ and sgardner@ and follow along @Kelhoops and @sophie_gardnerj. Vaccines 'THEY CROSSED THE LINE' — Dr. Fiona Havers, a CDC scientist who collected and compiled data on Covid-19 and respiratory syncytial virus before stepping down this week, told POLITICO that HHS Secretary Robert F. Kennedy Jr.'s overhaul of the agency's outside panel of vaccine experts was her final straw. 'I knew at that point that they had crossed the line,' Havers said. 'As a physician and a scientist, and for my own personal integrity, I did not feel like I could stay and legitimize this process.' The Advisory Committee on Immunization Practices votes on vaccine recommendations, playing an integral role in developing childhood and adult vaccine schedules. Last week, Kennedy fired the entire panel and replaced them with members he hand-selected. The first meeting of the new members is scheduled for next week. Havers often presented data to the panel to inform its decisions. I spoke with Havers about her decision to resign and what she will be watching for at next month's meeting. Here's our conversation, edited for length and clarity. What made you resign? [It was a] culmination over the last one to two months of RFK Jr. trashing the vaccine policy recommendation process at CDC. This has been building for a while. Several events have really undermined the vaccine policy process. One was in late May, when FDA officials released this regulatory framework suggesting that only those 65 years older and people with underlying medical conditions should receive [updated] Covid-19 vaccines. Then the following week, the HHS secretary announced on X that the Covid vaccines for healthy children and healthy pregnant women had been removed from the CDC recommended vaccine immunization schedule … Basically, RFK Jr. was making CDC vaccine policy on X without involving CDC. And that was pretty shocking, because there's a very rigorous process in place. Then last week, when they announced the firing of all 17 ACIP members, I knew I was done. Can you share any thoughts on Kennedy's replacement picks? These people are, for the most part — with very few possible exceptions — not the people that should be sitting on ACIP. What will you be watching at the meeting next week? If CDC is presenting the data … the data coming out of CDC is still solid. As of now, I can speak to the fact that the COVID-NET and RSV-NET data is high-quality evidence and can be believed. How those data get used to make vaccine policy decisions is really what's in question right now. Seeing the kind of questions that they ask and what they say may give some clue as to how they may vote in the future. I am very concerned that there's going to be a restricting of access to vaccines for people that otherwise should be getting them, and we'll get some sense of if that's actually going to happen. HHS response: HHS spokesperson Andrew Nixon told POLITICO that HHS is 'committed to following the gold standard of scientific integrity,' and 'vaccine policy decisions will be based on objective data, transparent analysis and evidence — not conflicts of interest or industry influence.' AROUND THE AGENCIES GAIN-OF-FUNCTION CUTS — The National Institutes of Health is cutting and suspending funding for gain-of-function research, a move that will impact biomedical projects conducted globally, Danny reports. The NIH's directive, released Wednesday, will immediately terminate funding and other support for gain-of-function research conducted by 'foreign entities in countries of concern or foreign countries where there is no adequate oversight.' The order didn't explicitly name the targeted groups and countries. The NIH did not respond to a request for comment. The agency will also suspend funding and additional support for all other gain-of-function research and has asked researchers who receive NIH funds to identify other projects not yet identified by the agency that fit the category by June 30. Gain-of-function research involves genetically altering biological organisms to enhance transmission or other functions, which can help scientists identify therapeutic targets. Key context: The move comes months after the Trump administration marked gain-of-function research as dangerous. Earlier this year, the administration said the Covid pandemic was caused by a lab leak from gain-of-function research at a virology research institute in the Chinese city of Wuhan, where the virus first appeared. Many scientists, however, believe the disease was caused by natural spillover from an animal to a human. The Trump administration's theory, memorialized in a glossy website unveiled in April, prompted President Donald Trump to issue an executive order last month to eliminate federal funding for gain-of-function research in countries such as China, which Trump has criticized for inadequate research oversight. The NIH's latest missive delivers on this executive order. In other research news: The FDA announced Wednesday it would immediately review new clinical trials that 'involve sending American citizens' living cells to China and other hostile countries for genetic engineering and subsequent infusion back into U.S. patients — sometimes without their knowledge or consent.' The order, endorsed by the NIH, is another swipe at foreign research — particularly studies performed in China, which the administration has characterized as poorly regulated. Industry Intel BURR'S LOBBYING GIG — The Biotechnology Innovation Organization, the world's largest biotech organization, has tapped former Republican Sen. Richard Burr (R-N.C.) to lobby on issues related to drug pricing and supply chains, Medicare and Medicaid and reauthorization of the Pandemic and All-Hazards Preparedness Act, Amanda reports. Now health policy chair at law firm DLA Piper, Burr was the top Republican on the Senate Health, Education, Labor and Pensions Committee and was a champion of reforming the FDA. Jamie Gregorian, a former senior policy adviser at the FDA and assistant to Burr in the Senate, will also represent BIO at DLA Piper, according to the law firm's disclosure submitted today. The outside hire from BIO marks the third for the group this year and comes as the biotech industry faces a steep drop in investor funding amid President Donald Trump's cuts to regulatory agencies. Earlier this week, BIO hired former Trump White House adviser Matt Mowers and Trump's campaign deputy director Bill Killion, who both now work at Valcour, a Washington-based lobbying firm. WHAT WE'RE READING POLITICO's Jordain Carney and Robert King report that Senate Republican leaders are seeking ways to tamp down moderates' worries about the megabill's possible impact on rural hospitals. The New York Times' Roni Caryn Rabin reports on the Trump administration's travel restrictions impacting medical residents.
Yahoo
an hour ago
- Yahoo
Scientists make concerning discovery after studying farmland soil: 'Highlights the urgent need for coordinated scientific and regulatory efforts'
Microplastics may be tiny in size, but a recent study shows they have a huge impact on our crops. Worrying new research has been highlighted by detailing the profound impact that microplastics have on soil and the crops that grow in contaminated areas. The study, originally published in the Environmental Sciences Europe journal, found that "agricultural soils now hold around 23 times more microplastics than oceans." The review stated that microplastics and nanoplastics have been discovered in lettuce, wheat, and carrot crops, with the lead researcher, Joseph Boctor, saying, "These microplastics are turning food-producing land into a plastic sink." Microplastics are flakes of plastic less than 5 millimeters in length. Plastics that can't biodegrade break down into smaller and smaller pieces, which are difficult to get rid of. They are incredibly pervasive, entering oceans, soil, animals, and human bodies. Animals and humans can consume the particles that end up in water, soil, and food sources, and microplastics may even be inhaled. Unfortunately, the presence of microplastics has been linked to serious health issues. A Washington Post article associated these tiny pollutants with a greater risk of heart disease, kidney disease, Alzheimer's, and fertility issues. "This review highlights the urgent need for coordinated scientific and regulatory efforts," Boctor said. "Regulators, scientists, and industry must collaborate to close the loopholes before plastic pollution further entrenches itself in the global food chain." In hopes of preventing the creation of microplastics in the future, Boctor and his colleagues at the Bioplastics Innovation Hub are in the process of creating plastic that decomposes in both soil and water. There are also a lot of things you can do in your everyday life that reduce microplastic pollution. The key thing to do is to move away from using plastic. More eco-friendly kitchen utensils and containers, made of materials such as wood, glass, or ceramic, can prevent the release of microplastics in the dishwasher. Do you worry about using cleaning products with harsh chemicals in them? All the time Sometimes Not really No — never Click your choice to see results and speak your mind. Another way microplastics are released is through the clothes we wear. Man-made fibers like nylon and polyester shed every time we wash our clothes, so try to choose natural fibers, such as cotton and linen, when you can. Installing a filter on your washing machine is another great way to prevent microplastics from polluting the water system. Though these tiny pollutants are proving to be a mammoth problem to tackle, there are many scientists working on ingenious solutions. For example, some researchers at the University of British Columbia have discovered they can filter up to 99.99% of microplastics from water using sawdust and plant-based tannins. At Princeton Engineering, researchers have found a way to clean microplastics out of the ocean by using egg whites, and it is only a matter of time until even more scientific solutions for microplastic pollution are created. Join our free newsletter for good news and useful tips, and don't miss this cool list of easy ways to help yourself while helping the planet.


USA Today
2 hours ago
- USA Today
U.S. Open winner J.J. Spaun's health issues posed greater threat than Oakmont
U.S. Open winner J.J. Spaun's health issues posed greater threat than Oakmont As soon as J.J. Spaun won the 2025 U.S. Open at Oakmont on Sunday, Andy Bessette fired off an email to Spaun to congratulate him. 'For a man with Type 1 diabetes to win the U.S. Open with four days of pressure – pressure is the enemy of Type I diabetes – I said with your burden there is nothing more amazing than you winning the U.S. Open,' said Bessette, executive vice president and chief administrative officer at Travelers and a hammer thrower on the 1980 U.S. Olympic Team. 'To me, it's one of the greatest accomplishments in sports given the burden he lives with.' In the fall of 2018, Spaun was diagnosed with Type 2 diabetes. 'I wasn't feeling great, so I knew something was up,' he said Wednesday during his press conference ahead of the Travelers Championship in Cromwell, Connecticut. The 34-year-old started taking medicine for Type 2 but still felt lethargic, kept losing weight and, most concerning, losing distance. By mid-2021 his ranking dipped to No. 584 in the Official World Golf Ranking. Before COVID canceled the 2020 Players Championship, Bessette was chatting with pro Harold Varner III, who expressed his concern that his pal Spaun was struggling with diabetes. Bessette's son, Chris, had been diagnosed with Type I diabetes at age 18, and Bessette was familiar with the disease – the beta cells in the pancreas stop working and produce zero insulin. Spaun goes into insulin shock if he doesn't control his insulin levels. Varner called Spaun via FaceTime to connect him with Bessette, who listened to his list of symptoms. 'I said, 'Are you sure you have Type 2?' You should get yourself checked by a good endocrinologist to make sure,' Bessette recalled advising. He made some calls on Spaun's behalf to the CEO of the Juvenile Diabetes Research Foundation (since renamed Breakthrough T1D), which funds research for the development of new therapies and treatments for type 1 diabetes. Spaun eventually discovered he was misdiagnosed. 'I just was kind of going through the whole learning experience of what diabetes is and how to treat it and how to approach this disease,' Spaun said. He has been approved by the Tour to wear a Libre blood-sugar monitor and check his levels while competing. If his blood sugar is low, he can faint. If it gets too high, his vision starts to blur. Later that year at the Travelers Championship, Spaun wedged to 19 inches in a closest-to-the-pin contest at the red floating umbrella in the middle of a lake dubbed hole No. 15 ½ at TPC River Highlands. As the winner, Spaun could donate $10,000 to the charity of his choice. He chose JDRF. Bessette was touched by Spaun's gesture and personally matched the donation. 'So that initiated our connection,' Spaun said. 'He's kind of been there for me the whole way, where if it was doctors I needed to get in touch with or CEOs of JDRF, it's been nice to have that connection and his network to kind of help me along this journey because I had just been diagnosed with it, but diagnosed incorrectly. Even when I got my diagnosis corrected, I guess, it was even more so helpful to have JDRF and Andy on my side to kind of help me navigate another new territory.' Bessette was moved again Sunday when Spaun achieved a career-defining moment at Oakmont – Type I Diabetes be damned. 'It changed his life,' Bessette said of being diagnosed correctly. 'It's a brutal disease.'